✦ LIBER ✦

Immunologically high-risk recipient strategies

✍ Scribed by M.R First

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk-benefit of OKT3 prophylaxis in immu

✍ F. Cogny-Van Weydevelt; L. Prud'Homme; A. Boucher; R. Dandavino 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 194 KB

Zenapax versus OKT-3 prophylaxis in immu

✍ J Lácha; M Sı́mová; L Nosková; V Teplan; S Vı́tko 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Failure of Ganciclovir Prophylaxis of Pr

✍ D.J. Conti; A. Isenberg; G.K. Shen; A. Hahn; T.P. Singh 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Tacrolimus, MMF, steroid, and ALG immuno

✍ J Zaltzman; V McAlister; D Russell; P Halloran; D Landsberg; S Busque; A Shoker; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 74 KB

An immunological algorithm to predict ri

✍ Silviu Itescu; Thomas CM Tung; Elizabeth M Burke; Alan D Weinberg; Donna Mancini 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 119 KB

Matching High-Risk Recipients With Margi

✍ Mark J. Russo; Ryan R. Davies; Kimberly N. Hong; Jonathan M. Chen; Michael Argen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 575 KB